| Amgen (AMGN) |
United States |
$147.580B |
15.43 |
| Bristol Myers Squibb (BMY) |
United States |
$146.079B |
10.41 |
| CSL (CSLLY) |
Australia |
$96.828B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$83.911B |
11.16 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$61.782B |
28.73 |
| Illumina (ILMN) |
United States |
$59.313B |
81.58 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$57.384B |
20.36 |
| Moderna (MRNA) |
United States |
$51.846B |
0.00 |
| Biogen (BIIB) |
United States |
$41.462B |
7.37 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$34.956B |
13.93 |
| BeiGene (BGNE) |
Cayman Islands |
$34.151B |
0.00 |
| Seagen (SGEN) |
United States |
$33.059B |
87.02 |
| Genmab (GMAB) |
Denmark |
$28.224B |
33.38 |
| Genmab (GNMSF) |
Denmark |
$26.832B |
6.18 |
| BioNTech SE (BNTX) |
Germany |
$24.536B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$22.564B |
0.00 |
| Incyte (INCY) |
United States |
$21.438B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$20.027B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$19.449B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$17.603B |
66.75 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$17.156B |
24.52 |
| Guardant Health (GH) |
United States |
$15.988B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$15.973B |
106.01 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$14.722B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$13.768B |
88.05 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$13.422B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$12.374B |
27.86 |
| Repligen (RGEN) |
United States |
$11.540B |
163.67 |
| Mirati Therapeutics (MRTX) |
United States |
$10.783B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$9.489B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$9.268B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$9.265B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$8.582B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$8.575B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$8.479B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$8.399B |
0.00 |
| Novavax (NVAX) |
United States |
$8.084B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$7.752B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$7.508B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$7.273B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.869B |
46.13 |
| Halozyme Therapeutics (HALO) |
United States |
$6.692B |
309.38 |
| NeoGenomics (NEO) |
United States |
$6.221B |
1867.67 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$6.009B |
17.57 |
| Beam Therapeutics (BEAM) |
United States |
$5.768B |
0.00 |
| Certara (CERT) |
United States |
$5.711B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$5.677B |
18.63 |
| Blueprint Medicines (BPMC) |
United States |
$5.649B |
18.70 |
| Amicus Therapeutics (FOLD) |
United States |
$5.496B |
0.00 |
| Vir Biotechnology (VIR) |
United States |
$5.163B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$4.991B |
0.00 |
| China Biologic Products (CBPO) |
China |
$4.655B |
30.17 |
| Arena Pharmaceuticals (ARNA) |
United States |
$4.518B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$4.393B |
0.00 |
| Insmed (INSM) |
United States |
$4.278B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$4.122B |
0.00 |
| Arvinas (ARVN) |
United States |
$4.071B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$3.868B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.867B |
139.95 |
| Legend Biotech (LEGN) |
United States |
$3.535B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.532B |
34.67 |
| I-Mab (IMAB) |
China |
$3.152B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$3.096B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.945B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.671B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$2.662B |
0.00 |
| Amarin (AMRN) |
Ireland |
$2.561B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.535B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.494B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$2.390B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$2.298B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.293B |
59.42 |
| Seres Therapeutics (MCRB) |
United States |
$2.195B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$2.115B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.057B |
17.03 |
| Myriad Genetics (MYGN) |
United States |
$2.003B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.974B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.959B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$1.933B |
0.00 |
| Viela Bio (VIE) |
United States |
$1.912B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.903B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.875B |
0.00 |
| NantKwest (NK) |
United States |
$1.873B |
0.00 |
| Vericel (VCEL) |
United States |
$1.873B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.849B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.747B |
0.00 |
| Precigen (PGEN) |
United States |
$1.708B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.658B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.619B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.604B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.596B |
0.00 |
| Heska (HSKA) |
United States |
$1.564B |
0.00 |
| Codexis (CDXS) |
United States |
$1.539B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.525B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.501B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.480B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$1.441B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.413B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$1.358B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.343B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$1.329B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.321B |
8.73 |
| Alector (ALEC) |
United States |
$1.315B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$1.307B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$1.305B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$1.227B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.195B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.163B |
0.00 |
| Athenex (ATNX) |
United States |
$1.156B |
0.00 |
| Mesoblast (MESO) |
Australia |
$1.087B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$1.063B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$1.031B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$1.024B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.992B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.986B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.972B |
0.00 |
| Morphic Holding (MORF) |
United States |
$0.971B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.954B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.940B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.908B |
24.17 |
| Merus (MRUS) |
Netherlands |
$0.860B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.858B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.855B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.827B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.827B |
0.00 |
| MannKind (MNKD) |
United States |
$0.823B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.808B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.778B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.777B |
39.44 |
| VBI Vaccines (VBIV) |
United States |
$0.746B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.729B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.704B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.698B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.697B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.685B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.670B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.669B |
0.00 |
| Agenus (AGEN) |
United States |
$0.654B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.651B |
0.00 |
| Curis (CRIS) |
United States |
$0.645B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.639B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.600B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.590B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.579B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.576B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.575B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.563B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.559B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.559B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.554B |
74.92 |
| Prothena (PRTA) |
Ireland |
$0.543B |
0.00 |
| Geron (GERN) |
United States |
$0.537B |
0.00 |
| Pandion Therapeutics (PAND) |
United States |
$0.535B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.511B |
0.00 |
| FORTE BIOSCIENC (FBRX) |
United States |
$0.500B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.486B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.478B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.475B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.474B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.458B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.454B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.454B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.443B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.439B |
0.00 |
| XOMA (XOMA) |
United States |
$0.433B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.426B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.419B |
19.71 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.417B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.397B |
10.09 |
| Cardiff Oncology (CRDF) |
United States |
$0.385B |
0.00 |
| Athersys (ATHX) |
United States |
$0.384B |
0.00 |
| NextCure (NXTC) |
United States |
$0.375B |
0.00 |
| Verastem (VSTM) |
United States |
$0.374B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.372B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.366B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.355B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.355B |
0.00 |
| Trevena (TRVN) |
United States |
$0.347B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.344B |
0.00 |
| AMMO (POWW) |
United States |
$0.342B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.339B |
8.69 |
| Fortress Biotech (FBIO) |
United States |
$0.332B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.309B |
14.48 |
| CytomX Therapeutics (CTMX) |
United States |
$0.307B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.304B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.303B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.301B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.282B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.279B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.279B |
0.00 |
| Cerecor (CERC) |
United States |
$0.262B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.253B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.246B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.242B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.230B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.224B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.222B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.215B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.214B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.210B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.209B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.204B |
0.00 |
| Exicure (XCUR) |
United States |
$0.204B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.197B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.197B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.195B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.194B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.191B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.185B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.183B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.182B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.180B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.169B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.167B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.163B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.161B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.159B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.158B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.155B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.154B |
318.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.152B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.152B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.147B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.147B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.145B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.145B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.142B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.138B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.129B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.129B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.127B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.127B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.125B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.123B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.122B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.116B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.114B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.110B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.110B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.105B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.102B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.099B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.093B |
0.00 |
| Stealth BioTherapeutics (MITO) |
United States |
$0.093B |
44.75 |
| Windtree Therapeutics (WINT) |
United States |
$0.092B |
0.00 |
| Adocia (ADOCY) |
France |
$0.091B |
0.00 |
| CytRx (CYTR) |
United States |
$0.089B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.083B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.075B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.072B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.070B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.069B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.066B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.065B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.061B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.061B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.060B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.057B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.057B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.055B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.055B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.054B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.053B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.053B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.052B |
0.00 |
| Celsion (CLSN) |
United States |
$0.051B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.051B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.049B |
0.00 |
| Chanticleer Holdings (SONN) |
United States |
$0.047B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.044B |
0.00 |
| Spherix (AIKI) |
United States |
$0.043B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.043B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.041B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.041B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.041B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.036B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.025B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.021B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.018B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.015B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.015B |
0.00 |
| CTD Holdings (CYTH) |
United States |
$0.010B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.007B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.005B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |
| Zai Lab (ZLAB) |
China |
$0.000B |
0.00 |
